4Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapob:the unappreciated atherogenic dys1ipoproteinemia in type 2 diabetes mellitus[J]. Ann Intern Med, 2001,135(6):447-459.
5Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function implications for atherosclerosis[J]. J Am Coll Nutr, 2001,20(2): 97-105.
6Silveira A. Postprandial triglycerides and blood coagulation[J]. Exp Clin Endocrinol Diabetes,2001,109(4):527-532.
7Mennen LI, Schouten EG, Grobbee DE, et al. Coagulation factor Ⅶ, dietary fat and blood lipids:a review[J]. Thromb Haemost,1996,76(4):492-499.
8Wong TY, Poon P, Szeto CC, et al. Association of plainogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients[J]. Kidney Int, 2000,57(2):632-638.
9Hodis HN. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis[J]. Circulation,1999,99(22):2 852-2 854.
10Lamarche B, Tchernof A, Moorjani S, et al. all, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovuscular Study[J]. Circulation,1997,95(1):69-75.
